Weekly reads: freeze-dried cloning, FDA signals, stem cell escapees

Cloning is one of those topics that both fascinates and kind of scares people, especially the idea of duplicating people.

I regularly cover the topic here on The Niche because stem cell technologies are involved. Also, one form of the process sometimes called “therapeutic cloning” involves embryonic stem cells.

Duplicating mammals has now long been a reality and similar methods could eventually be tried in people.

Artist Daisuke Takakura’s representation of human cloning.

In fact, as technology has advanced, human cloning has become more possible, so we’ll start with clone research but this time done in mice. It still has broader implications.

Cloning a new way

Healthy cloned offspring derived from freeze-dried somatic cells, Nat Comm. This comes from the Teruhiko Wakayama group.

One of the most striking things about this new paper is that some of the somatic cells or nuclei used had seemed essentially dead or damaged, but still apparently worked to clone new mice.

Why is this important?

Many folks interested in human cloning and perhaps even cloning of pets, might have to turn to preserved somatic cells such as skin biopsies or blood samples to attempt cloning. Teru’s new work suggests even frozen samples might work.

More recommended reads

1 thought on “Weekly reads: freeze-dried cloning, FDA signals, stem cell escapees”

  1. Is iPSC cloning at cellular level…..what is a well regulated from a science point of view of cellular cloning ?

Leave a Reply